James D. Swift - 01 Mar 2023 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Award	$0	+49,758	+71%	$0.000000	119,740	01 Mar 2023	Direct	F1, F2
transaction	MD	Common Stock	Tax liability	$155,968	-9,909	-8.3%	$15.74	109,831	01 Mar 2023	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan.
F2	Excludes 17,974 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved.
F3	Represents 9,909 restricted shares withheld for payment of taxes upon vesting of shares.